Details for Patent: 8,114,021

Which drugs does patent 8,114,021 protect, and when does it expire?

Patent 8,114,021 protects ABILIFY MYCITE KIT and is included in one NDA.

This patent has sixty-four patent family members in twenty countries.

Summary for Patent: 8,114,021

Title:	Body-associated receiver and method
Abstract:	Receivers, which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems.
Inventor(s):	Timothy Robertson, Fataneh Omidvar, Yashar Behzadi, Lawrence Arne, Kenneth Rowberry, James Hutchison, Robert Leichner, George Savage, Andrew Thompson, Mark Zdeblick, Marc Kreidler, Hooman Hafezi, Robert Duck
Assignee:	Otsuka Pharmaceutical Co Ltd
Application Number:	US12/673,326
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,114,021
Patent Claim Types: see list of patent claims	Delivery; Device;

Drugs Protected by US Patent 8,114,021

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-001	Nov 13, 2017		DISCN	Yes	No	8,114,021		Y
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-002	Nov 13, 2017		DISCN	Yes	No	8,114,021		Y
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-003	Nov 13, 2017		DISCN	Yes	No	8,114,021		Y
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-004	Nov 13, 2017		DISCN	Yes	No	8,114,021		Y
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-005	Nov 13, 2017		DISCN	Yes	No	8,114,021		Y
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-006	Nov 13, 2017		DISCN	Yes	No	8,114,021		Y

Foreign Priority and PCT Information for Patent: 8,114,021

PCT Information
PCT Filed	December 15, 2009	PCT Application Number:	PCT/US2009/068128
PCT Publication Date:	July 01, 2010	PCT Publication Number:	WO2010/075115

International Family Members for US Patent 8,114,021

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2009330321
Australia	2012284125
Brazil	112014001397
Canada	2747156
Canada	2792224
Canada	2842952